Drug Shortage Report for CEFAZOLIN FOR INJECTION, USP

Last updated on 2019-09-13 History
Report ID 88723
Drug Identification Number 02237138
Brand name CEFAZOLIN FOR INJECTION, USP
Common or Proper name Cefazolin for Injection
Company Name FRESENIUS KABI CANADA LTD
Active Ingredient(s) CEFAZOLIN
Strength(s) 1.0G
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS
Packaging size 1g Vial
ATC code J01DB
ATC description OTHER BETA-LACTAM ANTIBACTERIALS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-07-04
Estimated end date 2019-09-06
Actual end date 2019-09-06
Shortage status Resolved
Updated date 2019-09-13
Company comments
Health Canada comments
Contact Address 165 GALAXY BLVD, SUITE 100
TORONTO, ONTARIO
CANADA M9W 0C8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2019-09-13 French Compare
v4 2019-09-13 English Compare
v3 2019-07-05 French Compare
v2 2019-07-05 French Compare
v1 2019-07-05 English Compare